...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Formulation and Evaluation of Self-Micro Emulsifying Drug Delivery System for BCS Class - II Drug Ketoprofen
【24h】

Formulation and Evaluation of Self-Micro Emulsifying Drug Delivery System for BCS Class - II Drug Ketoprofen

机译:BCS-II类药物酮洛芬自微乳化递药系统的研制与评价

获取原文
           

摘要

Ketoprofen, a widely prescribed analgesic drug which belongs to BCS class II and exhibit low and variable oral bioavailability due to its poor aqueous solubility. To enhance the solubility and dissolution rate of poorly water soluble drug Ketoprofen, Self-micro emulsifying drug delivery system (SMEDDS) was developed and evaluated. Solubility study, emulsification ability, ternary phase diagram and central composite design (CCD) were used as primary tools to select the components of the system and optimize the composition of liquid Ketoprofen SMEDDS. The globule size of optimized liquid SMEDDS was 105.08±5.16nm, zeta potential -4.23mV and polydispersity index 0.097, % Transmittance 98.45% and self emulsification time 28 sec. Optimized formulation F3 containing Oleic acid (10%), Tween 80 (30%) and Propylene glycol (60%) was adsorbed onto inert solid carrier Aerosil 200 in 1:1 ratio to form dry, free flowing powder. The liquid crystal phase viscosity increased significantly with increasing amount of aerosil 200 which in turn increases average globule size of solid SMEDDS (303.69±0.933nm) and slowers drug release. S-SMEDDS also characterized for DSC, XRD, SEM etc. The in vitro dissolution study indicates improved dissolution characteristics with higher percent drug release for solid SMEDDS (89.78%) compared to marketed preparation (81.26%) and pure drug (71.32%). In conclusion, S-SMEDDS for Ketoprofen holds promise to be developed as potential system for improved oral delivery.
机译:酮洛芬是一种广泛使用的止痛药,属于BCS II类,由于水溶性差,口服生物利用度低而可变。为了提高水溶性差的药物酮洛芬的溶解度和溶解速度,开发并评估了自微乳化药物递送系统(SMEDDS)。溶解度研究,乳化能力,三元相图和中心复合设计(CCD)被用作选择系统组分和优化液体酮洛芬SMEDDS组成的主要工具。优化的液体SMEDDS的球尺寸为105.08±5.16nm,ζ电势为-4.23mV,多分散指数为0.097,透光率为98.45%,自乳化时间为28秒。将含有油酸(10%),吐温80(30%)和丙二醇(60%)的优化配方F3以1:1的比例吸附到惰性固体载体Aerosil 200上,形成干燥,自由流动的粉末。液晶相粘度随aerosil 200含量的增加而显着增加,这反过来又增加了固体SMEDDS的平均球尺寸(303.69±0.933nm),并减缓了药物的释放。 S-SMEDDS还具有DSC,XRD,SEM等特性。体外溶出研究表明,与市售制剂(81.26%)和纯药物(71.32%)相比,固体SMEDDS(89.78%)的药物释放百分比更高,溶出特性得到改善。总之,酮洛芬的S-SMEDDS有望被开发为改善口服给药的潜在系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号